首页> 外文OA文献 >Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial
【2h】

Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial

机译:混合抑郁症中Theta-Burst刺激的功效,安全性和耐受性:随机,双盲,假手动试验的设计,理论和目标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionMixed-specifier mood disorders are probably a different subgroup in terms of response to treatment, socio-demographic parameters, course, and family history. Here we describe the rationale and design of a clinical trial aimed to test the efficacy, safety, and tolerability of a non-pharmacological treatment known as theta-burst stimulation (TBS) for treating the mixed depressive episodes of both bipolar (I or II), and unipolar depression.MethodsThe study is designed as a randomized, sham-controlled, double-blinded clinical trial evaluating TBS for the treatment of moderate or severe major depressive episodes with mixed features of patients receiving at least one first or second-line pharmacological treatment for depressive episodes without adequate response. Ninety adult (18 to 65 years old) patients will be enrolled and submitted to 6-week (comprising 5 consecutive days a week sessions for the first 3 weeks and then 2 days a week for a further 3 week) of inhibitory followed by excitatory TBS in dorsolateral prefrontal cortex. Participants will be assessed using clinical and neuropsychological tests before and after the intervention. The primary outcome is change in Montgomery–Åsberg Depression Scale (MADRS) score over time and across groups. Cognitive parameters will also be assessed with neuropsychological tests.ResultsThe clinical results will provide evidence about TBS as an adjunctive treatment for mixed depression treatment and neuropsychological parameters will contribute toward an improved understanding the effects of TBS in cognition.ConclusionOur results could introduce a novel therapeutic technique for mixed depressive episodes of both bipolar and unipolar disorders.Clinical Trial Registrationwww.ClinicalTrials.gov, identifier NCT04123301; date of registration: 10/10/2019; URL: https://clinicaltrials.gov/ct2/show/NCT04123301?term=NCT04123301&rank=1.
机译:引入说明书 - 说明书的情绪障碍可能是对治疗,社会人口统计参数,课程和家族历史的响应方面不同的子组。在这里,我们描述了临床试验的理由和设计,旨在测试称为突发刺激(TBS)的非药理学治疗的疗效,安全性和可耐受性,用于治疗双极(I或II)的混合抑郁发作和UniPolear抑郁症。近似研究的研究是设计为随机,假的双盲的临床试验,用于治疗中度或严重的主要抑郁发作,其患者的混合特征在于接受至少一个第一或二线药理治疗对于没有足够反应的抑郁发作。九十成年人(18至65岁)患者将注册并提交6周(连续5天,每周连续3周,然后是每周2天,然后每周2天)抑制性兴奋性TBS在背面层前额叶皮质。参与者将在干预前后使用临床和神经心理学测试进行评估。主要结果是蒙哥马利 - Åsberg抑郁症(Madrs)评分随着时间的推移和跨组的变化。也将通过神经心理学测试评估认知参数。临床结果将提供关于TBS作为混合抑郁症治疗的辅助治疗的证据,并且神经心理学参数将有助于了解TBS在认知中的影响。结论,结果可以引入一种新的治疗技术对于双极和单极性紊乱的混合抑郁情节。临床试验登记纽扣.Clinicaltrials.gov,标识符NCT04123301;注册日期:10/10/2019; URL:https://clinicaltrials.gov/ct2/show/nct04123301?TERM = NCT04123301&RAKN = 1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号